Olema Pharmaceuticals inc (OLMA)
10.67
+0.60
(+5.96%)
USD |
NASDAQ |
May 03, 16:00
10.66
-0.01
(-0.09%)
After-Hours: 20:00
Olema Pharmaceuticals 1 Year Total Returns (Daily): 78.43% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 78.43% |
| May 02, 2024 | 84.10% |
| May 01, 2024 | 91.53% |
| April 30, 2024 | 112.3% |
| April 29, 2024 | 112.1% |
| April 26, 2024 | 129.3% |
| April 25, 2024 | 140.9% |
| April 24, 2024 | 151.2% |
| April 23, 2024 | 141.0% |
| April 22, 2024 | 137.8% |
| April 19, 2024 | 148.2% |
| April 18, 2024 | 167.6% |
| April 17, 2024 | 189.5% |
| April 16, 2024 | 195.6% |
| April 15, 2024 | 196.4% |
| April 12, 2024 | 208.5% |
| April 11, 2024 | 250.0% |
| April 10, 2024 | 233.5% |
| April 09, 2024 | 250.5% |
| April 08, 2024 | 242.6% |
| April 05, 2024 | 232.3% |
| April 04, 2024 | 224.4% |
| April 03, 2024 | 217.5% |
| April 02, 2024 | 212.4% |
| April 01, 2024 | 213.8% |
| Date | Value |
|---|---|
| March 28, 2024 | 222.5% |
| March 27, 2024 | 224.6% |
| March 26, 2024 | 204.2% |
| March 25, 2024 | 204.7% |
| March 22, 2024 | 229.3% |
| March 21, 2024 | 217.3% |
| March 20, 2024 | 222.2% |
| March 19, 2024 | 218.2% |
| March 18, 2024 | 205.2% |
| March 15, 2024 | 190.2% |
| March 14, 2024 | 196.7% |
| March 13, 2024 | 218.1% |
| March 12, 2024 | 212.1% |
| March 11, 2024 | 234.2% |
| March 08, 2024 | 234.2% |
| March 07, 2024 | 273.2% |
| March 06, 2024 | 262.3% |
| March 05, 2024 | 237.3% |
| March 04, 2024 | 255.1% |
| March 01, 2024 | 269.1% |
| February 29, 2024 | 202.4% |
| February 28, 2024 | 216.3% |
| February 27, 2024 | 252.7% |
| February 26, 2024 | 230.0% |
| February 23, 2024 | 211.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.89%
Minimum
Apr 18 2022
506.5%
Maximum
Nov 20 2023
51.74%
Average
-21.93%
Median
1 Year Total Returns (Daily) Benchmarks
| Geron Corp | 47.19% |
| Verastem Inc | 106.4% |
| Fate Therapeutics Inc | -35.76% |
| Karyopharm Therapeutics Inc | -69.13% |
| Alpine Immune Sciences Inc | 824.2% |